WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Davalintide

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Amyloidogenicity of peptides targeting diabetes and obesity.

    DOI: 10.1016/j.colsurfb.2021.112157PMID: 34715595

    Source identity and connection checked by Codex (AI).

  2. Current Drug Targets in Obesity Pharmacotherapy - A Review.

    DOI: 10.2174/1389450118666170227153940PMID: 28245771

    Source identity and connection checked by Codex (AI).

  3. Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.

    DOI: 10.1007/s13679-018-0300-4PMID: 29504049

    Source identity and connection checked by Codex (AI).

  4. Simultaneous quantification of davalintide, a novel amylin-mimetic peptide, and its active metabolite in beagle and rat plasma by online SPE and LC-MS/MS.

    DOI: 10.4155/bio.12.184

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Wang Y
  • Qu Y
  • Bellows CL
  • Ahn JS
  • Burkey JL
  • Taylor SW
  • Lima LMTR
  • Icart LP
  • Srivastava G
  • Apovian C
  • Bhat SP
  • Sharma A